Schedule 13G ownership disclosure

CRISPR Therapeutics AG

Security class unavailable · CUSIP: H17182108

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-23-001563
Form type
SC 13G/A
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Feb 03, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub